Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Neutral tumor evolution?

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Get just this article for as long as you need it


Prices may be subject to local taxes which are calculated during checkout

Fig. 1: M(f) ~ 1/f is an uninformative test for identifying (non-)neutrality in simulated and real data.

Data availability

This study used data generated by the The Cancer Genome Atlas (TCGA, a collection of publicly available data from human tissues; We ran dN/dS analyses on the data from TCGA, using published CaVeMan19,20 single-nucleotide variant calls, and ASCAT21 copy number calls, as described in Martincorena et al.13. Simulation data can be reproduced by using the R and Java scripts provided.


  1. Greaves, M. & Maley, C. C. Nature 481, 306–313 (2012).

    Article  CAS  Google Scholar 

  2. Yates, L. R. & Campbell, P. J. Nat. Rev. Genet. 13, 795–806 (2012).

    Article  CAS  Google Scholar 

  3. Andor, N. et al. Nat. Med. 22, 105–113 (2016).

    Article  CAS  Google Scholar 

  4. Nowell, P. C. Science 194, 23–28 (1976).

    Article  CAS  Google Scholar 

  5. Nik-Zainal, S. et al. Cell 149, 994–1007 (2012).

    Article  CAS  Google Scholar 

  6. Dentro, S. C., Wedge, D. C. & Van Loo, P. Cold Spring Harb. Perspect. Med. 7, a026625 (2017).

    Article  Google Scholar 

  7. Williams, M. J., Werner, B., Barnes, C. P., Graham, T. A. & Sottoriva, A. Nat. Genet. 48, 238–244 (2016).

    Article  CAS  Google Scholar 

  8. Johnson, D. C. et al. Blood 130, 1639–1643 (2017).

    Article  CAS  Google Scholar 

  9. Zack, T. I. et al. Nat. Genet. 45, 1134–1140 (2013).

    Article  CAS  Google Scholar 

  10. Bozic, I., Gerold, J. M. & Nowak, M. A. PLoS Comput. Biol. 12, e1004731 (2016).

    Article  Google Scholar 

  11. Nei, M. & Gojobori, T. Mol. Biol. Evol. 3, 418–426 (1986).

    CAS  PubMed  Google Scholar 

  12. Goldman, N. & Yang, Z. Mol. Biol. Evol. 11, 725–736 (1994).

    CAS  PubMed  Google Scholar 

  13. Martincorena, I. et al. Cell 171, 1029–1041.e21 (2017).

    Article  CAS  Google Scholar 

  14. Forbes, S. A. et al. Nucleic Acids Res. 45, D777–D783 (2017).

    Article  CAS  Google Scholar 

  15. Williams, M. J. et al. Nat. Genet. 50, 895–903 (2018).

    Article  CAS  Google Scholar 

  16. Al Hammal, O., Alonso, D., Etienne, R. S. & Cornell, S. J. PLoS Comput. Biol. 11, e1004134 (2015).

    Article  Google Scholar 

  17. Herzog, H. A., Bentley, R. A. & Hahn, M. W. Proc. R. Soc. Lond. B 271, S353–S356 (2004).

    Article  Google Scholar 

  18. Leigh, E. G. Jr. J. Evol. Biol. 20, 2075–2091 (2007).

    Article  Google Scholar 

  19. Varela, I. et al. Nature 469, 539–542 (2011).

    Article  CAS  Google Scholar 

  20. Jones, et al. Curr. Protoc. Bioinforma. 56, 15.10.1–15.10.18 (2016).

    Article  Google Scholar 

  21. Van Loo, et al. Proc. Natl Acad. Sci. 107, 16910–16915 (2010).

    Article  CAS  Google Scholar 

Download references


This work was supported by The Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001202), the UK Medical Research Council (FC001202) and the Wellcome Trust (FC001202) (M.T. and P.V.L.). M.T. is supported as a postdoctoral fellow by the European Union’s Horizon 2020 research and innovation program (Marie Skłodowska-Curie Grant agreement no. 747852-SIOMICS). P.V.L. is a Winton Group Leader in recognition of the Winton Charitable Foundation’s support toward the establishment of The Francis Crick Institute. I.M. is funded by a Cancer Research UK Career Development Fellowship (C57387/A21777). D.C.W. is funded by the Li Ka Shing Foundation. This work was supported by grant 1U24CA210957 to P.T.S.. F.M. acknowledges support from the University of Cambridge, Cancer Research UK and Hutchison Whampoa Limited. Parts of this work were funded by Cancer Research UK core grant C14303/A17197 (F.M.). This project was enabled through access to the MRC eMedLab Medical Bioinformatics infrastructure, supported by the UK Medical Research Council (grant no. MR/L016311/1) (M.T. and P.V.L.). Parts of the results published here are based on data generated by the TCGA Research Network (

Author information

Authors and Affiliations




M.T., I.M., M.G., A.M.L., F.M., P.T.S., Q.D.M., O.C.L., D.C.W. and P.V.L. participated in argumentation. M.T., O.C.L., D.C.W. and P.V.L. derived the deterministic equations. M.T. wrote the code and generated the figures, with input from I.M., M.G., O.C.L., D.C.W. and P.V.L.; M.T., O.C.L., D.C.W. and P.V.L. drafted the manuscript, which was revised by I.M., M.G., A.M.L., F.M., P.T.S. and Q.D.M. All authors read and approved the manuscript.

Corresponding author

Correspondence to Peter Van Loo.

Supplementary information

Supplementary Text and Figures

Supplementary Note and Supplementary Figures 1–3

Reporting Summary

Supplementary Software

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Tarabichi, M., Martincorena, I., Gerstung, M. et al. Neutral tumor evolution?. Nat Genet 50, 1630–1633 (2018).

Download citation

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer